期刊文献+

用MTT比色法建立B型CpGODN活性检测标准 被引量:2

Determination of optimized MTT colorimetric assay as the identification method for the activity of B type CpG ODN BW006
下载PDF
导出
摘要 目的:B型CpG ODN,BW006作为疫苗佐剂已进入临床试验阶段,所以需要建立稳定、安全、简便易行的活性检测方法以控制不同批次BW006的生产质量。方法:根据BW006具有刺激人PBMC和小鼠脾细胞增生的特点,选择无放射性污染的MTT比色法作为首选检测方案。用BW006刺激BALB/c小鼠脾细胞作为筛选平台,确定如下反应条件:脾细胞用量、培养板形状、BW006浓度、培养液体积和培养时间以及如何优化MTT检测过程以提高反应灵敏度。结果:用3 mg/LBW006与96孔平底板中含100 mL/LFBS的200μL无酚红RPMI1640培养的6×105个小鼠脾细胞在37℃含50 mL/L CO2孵箱中共孵育36 h。随后每孔弃100μL上清,加入MTT(5 g/L)10μL,37℃避光孵育4 h使各孔充分形成甲瓒颗粒。每孔加入DMSO 150μL,经平板振荡器振荡20 min至颗粒完全溶解,在酶标仪上检测A578值即可。结论:建立了无污染、造价低、可操作性强的BW006活性检测方法。 AIM: BW006, B type CpG ODN, will be approved as vaccine adjuvant for human use. So it is necessary to determine a stable, safety and easy-to-operate method for activity identification of BW006 with different lots. METHODS: According to the characteristic of BW006 to stimulate the proliferation of PBMC or mice splenocytes, MTT assay was preferentially selected to test the characteristic of BW006. The splenocytes of female BALB/c mice was stimulated by BW006, and different experiment parameters including splenocyte numbers, the shape of plate, BW006 concentration, culture medium, culture time and optimized MTT conditions were determined in these courses. RESULTS: the whole experiment scheme was defined as following: 6 × 10^5 splenocytes were co-cultured with 3 mg/L BW006 in 200 microliter RPMI1640(without phenol red) supplemented with 100 mL/L FBS in a 96 well square plate. PBS, the solvent of BW006 was used as negative control, and culture medium without cells was used as blank. After being co-cultured for 36 hours at 37℃; in humidified incubator with 50 mL/L CO2, 100 microliter supernatants was aspired out and 10 microliter MIF (5 g/L) was added into each well. The plate was further incubated in dark at 37℃ for 4 hours that is sufficient for the formation of formazan. Afterward, 150 microliter DMSO was directly added into each well. The plate was shaken on plate shaker for nearly 20 minutes until the formazan was completely dissolved and detected A578 value at at ELISA reader. CONCLUSION: optimized MTT assay, which is non-radioactive contamination, low-price and simple operation, could be used as activity identification of BW006 during large-scale production.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2008年第1期69-71,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金海外杰出青年基金资助项目(30328010)
关键词 MTY比色法 脾细胞增生 BW006 活性 MTr assay proliferation BW006 activity
  • 相关文献

参考文献8

  • 1Krieg AM. Therapeutic potential of Toll-like receptor 9 activation[ J]. Nat Rev Drug Discov, 2006, 5(6) : 471 -484.
  • 2王学菊,王智博,卫红飞,吴秀丽,王莉,于永利,王丽颖.C型CpG单链寡核苷酸对肿瘤疫苗抑瘤效果的增强作用[J].细胞与分子免疫学杂志,2007,23(4):338-340. 被引量:4
  • 3Guy B. The perfect mix : recent progress in adjuvant research [ J ]. Nat Rev Microbiol, 2007, 5(7): 505-517.
  • 4Lin DS. Comparison of three non-radioactive assays for measurement of cell-mediated immunity[J]. Bio Formosa, 2006, 41(2) : 59 -66.
  • 5Meletiadis J, Mouton JW, Meisjf GM, et al. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2, 3-bis [ 2-methoxy-4-nitro-5-[ ( sulfenylamino ) carbonyl ] -2H-tetrazolium-hydroxide ], for antifungal susceptibility testing of aspergillus species[J]. J Cin Microbiol, 2001, 39(12) : 4256 -4263.
  • 6Patel MI, Tuckerman R, Dong QH. A Pitfall of the 3-(4, 5-dimethyl- thiazol-2-yl )-5 ( 3-carboxymethonyphenol )-2-( 4-sulfophenyl )-2H- tetrazolium (MTS) assay due to evaporation in wells on the edge of a 96 well plate [ J ]. Biotechnology Letters, 2005, 27 ( 11 ) : 805 - 808.
  • 7Mannon RB, Nataraj C, Pisetsky DS. Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides[ J ]. Cell Immunol, 2000, 201(1) : 14 -21.
  • 8Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation[J]. Nature, 1995, 374(6522) : 546 -549.

二级参考文献6

  • 1袁时芳,李开宗,王岭,颜真,韩苇,张英起.GM-CSF对MUC1基因疫苗抑制乳腺癌生长的增强作用[J].细胞与分子免疫学杂志,2004,20(6):737-740. 被引量:7
  • 2Finkelman FD,Holmes J,Katona IM,et al.Lymphokine control of in vivo immunoglobulin isotype selection[J].Annu Rev Immunol,1990,8(5):303-333.
  • 3Rafiq K,Bergtold A,Clynes R.Immune complex-mediated antigen presentation induces tumor immunity[J].J Clin Invest,2002,110(1):71-79.
  • 4Krieg AM.CpG motifs in bacterial DNA and their immune effects[J].Annu Rev Immunol,2002,20:709-760.
  • 5Chu S,Targoni S,Krieg AM,et al.CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity[J].J Exp Med,1997,186(10):1623-1631.
  • 6Sparwasser T,Miethke T,Lipford G,et al.Bacterial DNA causes septic shock[J].Nature,1997,386(6623):336-337.

共引文献3

同被引文献10

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部